EUVIMEDEUVIMED entdecken
Open Access

NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression

Thejaswini Giridharan, Sora Suzuki, Anm Nazmul H Khan, Qian Liu iD, Kristopher Attwood iD, Anna Stokolosa iD, Sidney Mahan, Agnieszka K Witkiewicz, Janine Joseph iD, Kirsten Moysich, Solomon Langermann iD, Rustin Lovewell und 9 weitere

The Journal of Immunology · 01.09.2025 · 214 (9) · 2464-2479

DOI: 10.1093/jimmun/vkaf121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 25.06.2025. Verfasst von Thejaswini Giridharan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Michigan, Ann Arbor, MI, United States. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neutrophils, Receptors, Immunologic, T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BHS, NCI NIH HHS, KBM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously observed that circulating human neutrophils exposed to epithelial ovarian cancer (OC) ascites fluid supernatants (ASC) and malignant effusions from other tumors acquire T cell suppressor function. Collagen motifs ligate LAIR-1, an inhibitory SHP-1-dependent checkpoint broadly expressed on immune cells. We hypothesized that NC410, a bivalent LAIR-2 construct that inhibits LAIR-1-collagen binding, would rescue neutrophil-driven T cell non-responsiveness. NC410 remodeled ASC collagen resulting in neutrophil clustering and reduction in neutrophil-T cell contact, abrogated ASC-induced neutrophil trogocytosis of T cell membranes and rescued stimulated T cell proliferation. Mean ASC pro-collagen-1α levels were >100-fold greater than serum samples. In a single-center retrospective analysis, after adjusting for age, stage and optimal debulking, ASC pro-collagen-1α and serum sLAIR-1 levels were each associated with worse overall survival (OS), and ASC LAIR-2 levels were associated with better OS. Multispectral imaging of high-grade serous ovarian cancer and non-small cell lung cancer showed highly variable LAIR-1 staining in both tumor cell and immune infiltrates. The proportion of collagen-1-positive cells was highest among tumor cells and tumor-infiltrating immune cells versus stromal immune cells, raising the potential role of tumor-associated collagen limiting immune cell infiltration into tumor. Our results support further evaluation of circulating and tumor-associated collagen products and LAIR-1 and LAIR-2 as prognostic biomarkers in advanced OC and as biomarkers for clinical response to NC410 and to other collagen- and LAIR-directed therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeutrophilsReceptors, ImmunologicT-LymphocytesOvarian NeoplasmsCollagenCarcinoma, Ovarian EpithelialHumansFemaleMiddle AgedRetrospective StudiesAged

Stichwörter der Autor:innen

ImmunosuppressionNeutrophilOvarian cancerT cellTumor microenvironment (TME)

Substanzen

Receptors, ImmunologicLAIR-2 receptorleukocyte-associated immunoglobulin-like receptor 1Collagen

Autor:innen und Institutionen

  • Department of Surgery, University of Michigan, Ann Arbor, MI, United States.
  • Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.
  • Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States.
  • Department of Molecular & Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.

ORCID-Profile: Qian Liu, Kristopher Attwood, Anna Stokolosa, Janine Joseph, Solomon Langermann, Dallas Flies, Kunle Odunsi, Prasenjit Dey

Förderung

  • BHS
  • NCI NIH HHS
  • KBM
  • NextCure Inc.
  • Comprehensive Cancer Support
  • NCI Comprehensive Cancer Support Grant
  • NextCure Inc
  • Roswell Park Comprehensive Cancer Center

Zitieren

APA

Giridharan, T., Suzuki, S., Khan, A. N. H., Liu, Q., Attwood, K., Stokolosa, A., Mahan, S., Witkiewicz, A. K., Joseph, J., Moysich, K., Langermann, S., Lovewell, R., Flies, D., Myint, H., Odunsi, K., Emmons, T. R., Yaffe, M. B., Zsiros, E., Dey, P., …, & Segal, B. H. (2025). NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. The Journal of Immunology, 214(9), 2464-2479. https://doi.org/10.1093/jimmun/vkaf121

Vancouver

Giridharan T, Suzuki S, Khan ANH, Liu Q, Attwood K, Stokolosa A, et al. NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. The Journal of Immunology. 2025;214(9):2464-2479. doi:10.1093/jimmun/vkaf121

BibTeX
@article{Giridharan2025,
  author = {Giridharan, Thejaswini and Suzuki, Sora and Khan, Anm Nazmul H and Liu, Qian and Attwood, Kristopher and Stokolosa, Anna and Mahan, Sidney and Witkiewicz, Agnieszka K and Joseph, Janine and Moysich, Kirsten and Langermann, Solomon and Lovewell, Rustin and Flies, Dallas and Myint, Han and Odunsi, Kunle and Emmons, Tiffany R and Yaffe, Michael B and Zsiros, Emese and Dey, Prasenjit and McGray, A J Robert and Segal, Brahm H},
  title = {NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression},
  journal = {The Journal of Immunology},
  year = {2025},
  volume = {214},
  number = {9},
  pages = {2464--2479},
  doi = {10.1093/jimmun/vkaf121}
}
Kostenlos starten →